Stefano Aliberti to Anti-Bacterial Agents
This is a "connection" page, showing publications Stefano Aliberti has written about Anti-Bacterial Agents.
Connection Strength
0.531
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. J Infect. 2019 10; 79(4):300-311.
Score: 0.165
-
Individualizing duration of antibiotic therapy in community-acquired pneumonia. Pulm Pharmacol Ther. 2017 08; 45:191-201.
Score: 0.144
-
COVID-19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis. 2020 Dec; 22(6):e13356.
Score: 0.044
-
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis. Respir Res. 2018 Oct 23; 19(1):205.
Score: 0.039
-
In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms. J Antimicrob Chemother. 2018 09 01; 73(9):2388-2395.
Score: 0.039
-
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017 09; 50(3).
Score: 0.036
-
An update on the pharmacotherapeutic management of lower respiratory tract infections. Expert Opin Pharmacother. 2017 Jul; 18(10):973-988.
Score: 0.036
-
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study. J Hosp Infect. 2018 Aug; 99(4):413-418.
Score: 0.009
-
European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 09; 50(3).
Score: 0.009
-
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling. Am J Respir Crit Care Med. 2017 09 01; 196(5):609-620.
Score: 0.009